Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Roberta Burnelli"'
Autor:
Valli De Re, Ombretta Repetto, Lara Mussolin, Giulia Brisotto, Caterina Elia, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, Maurizio Mascarin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long-term treatment-related side effects, however, so the past 20 years
Externí odkaz:
https://doaj.org/article/25b8bf36454644cabb8584bbed9308eb
Autor:
Valli De Re, Laura Caggiari, Maurizio Mascarin, Mariangela De Zorzi, Caterina Elia, Ombretta Repetto, Lara Mussolin, Marta Pillon, Paola Muggeo, Salvatore Buffardi, Maurizio Bianchi, Alessandra Sala, Luciana Vinti, Piero Farruggia, Elena Facchini, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, with the A.I.E.O.P. Consortium
Publikováno v:
Hemato, Vol 2, Iss 2, Pp 264-280 (2021)
Several studies have examined the prognostic performance of therapeutic groups (TG) and early responses to therapy on positron emission tomography/computed tomography (PET/CT) in children and adolescents with classical Hodgkin lymphoma (cHL); less re
Externí odkaz:
https://doaj.org/article/08f4de8f6dde494d9b95fba9dda98d7a
Autor:
Valli De Re, Laura Caggiari, Mariangela De Zorzi, Valentina Fanotto, Gianmaria Miolo, Fabio Puglisi, Renato Cannizzaro, Vincenzo Canzonieri, Agostino Steffan, Piero Farruggia, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, Lara Mussolin, Maurizio Mascarin
Publikováno v:
Infectious Agents and Cancer, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most of their functions are still unknown. Nonetheless, some new studies und
Externí odkaz:
https://doaj.org/article/60d10087c67341a291fdb61c04170598
Autor:
Egesta Lopci, Roberta Burnelli, Caterina Elia, Arnoldo Piccardo, Angelo Castello, Eugenio Borsatti, Pietro Zucchetta, Angelina Cistaro, Maurizio Mascarin
Publikováno v:
BMJ Open, Vol 11, Iss 3 (2021)
Introduction Assessment of response to therapy in paediatric patients with Hodgkin lymphoma (HL) by 18F-fluorodeoxyglucose positron emission tomography/CT has become a powerful tool for the discrimination of responders from non-responders. The additi
Externí odkaz:
https://doaj.org/article/c5a10b88ab8b417ea4bbd1b69015c33f
Autor:
Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández-Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Cepelova, Alexander Claviez, Karin Dieckmann, Judith Landman-Parker, Regine Kluge, Dieter Körholz, Christine Mauz-Körholz, William Hamish Wallace, Thierry Leblanc, on behalf of the EuroNet Paediatric Hodgkin Lymphoma Group
Publikováno v:
HemaSphere, Vol 4, Iss 1, p e329 (2020)
Abstract. The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or refractory (R/R) classical Hodgkin lymphoma (cHL). While salvage with standard dos
Externí odkaz:
https://doaj.org/article/d7343141f1694de29a9be7c881506871
Autor:
Ombretta Repetto, Federica Lovisa, Caterina Elia, Daniel Enderle, Filippo Romanato, Salvatore Buffardi, Alessandra Sala, Marta Pillon, Agostino Steffan, Roberta Burnelli, Lara Mussolin, Maurizio Mascarin, Valli De Re
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 917 (2021)
Exosomes and other small extracellular vesicles (EVs) are potential sources of cancer biomarkers. Plasma-derived EVs have not yet been studied in pediatric Hodgkin lymphoma (HL), for which predictive biomarkers of relapse are greatly needed. In this
Externí odkaz:
https://doaj.org/article/4a6829c228d742baac18d21e7c8cb32e
Autor:
Ombretta Repetto, Valli De Re, Lara Mussolin, Massimo Tedeschi, Caterina Elia, Maurizio Bianchi, Salvatore Buffardi, Alessandra Sala, Roberta Burnelli, Maurizio Mascarin
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6, p 2185 (2020)
The identification of circulating proteins associated with relapse in pediatric Hodgkin lymphoma (HL) may help develop predictive biomarkers. We previously identified a set of predictive biomarkers by difference gel electrophoresis. Here we used labe
Externí odkaz:
https://doaj.org/article/9ae58367f8334056a06ba7ae46b29358
Autor:
Egesta, Lopci, Caterina, Elia, Barbara, Catalfamo, Roberta, Burnelli, Valli, De Re, Lara, Mussolin, Arnoldo, Piccardo, Angelina, Cistaro, Eugenio, Borsatti, Pietro, Zucchetta, Maurizio, Bianchi, Salvatore, Buffardi, Piero, Farruggia, Alberto, Garaventa, Alessandra, Sala, Luciana, Vinti, Christine, Mauz-Koerholz, Maurizio, Mascarin
Publikováno v:
Journal of clinical medicine. 11(20)
Therapy response evaluation byPrimarily, the study aimed to compare the different segmentation techniques used for volumetric assessment in HL patients at baseline (PET1) and during therapy: early (PET2) and late assessment (PET3). Overall, 50 patien
Autor:
Davide Massano, Elisa Carraro, Lara Mussolin, Salvatore Buffardi, Veronica Barat, Daniele Zama, Paola Muggeo, Francesca Vendemini, Antonella Sau, Maria Luisa Moleti, Federico Verzegnassi, Salvatore D'Amico, Tommaso Casini, Alberto Garaventa, Elisabetta Schiavello, Monica Cellini, Luciana Vinti, Piero Farruggia, Katia Perruccio, Simone Cesaro, Raffaela De Santis, Maddalena Marinoni, Irene D'Alba, Rosa Maria Mura, Roberta Burnelli, Maurizio Mascarin, Marta Pillon
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(10)
Brentuximab vedotin (BV) is an antibody drug-conjugated anti-CD30 approved for the treatment of adult classical Hodgkin's lymphoma (HL), whereas it is considered as off-label indication in paediatrics. The aim of the study was to evaluate the safety
Autor:
Daniele Zama, Francesco Baccelli, Antonella Colombini, Amalia Contino, Elisabetta Calore, Maria Grazia Petris, Linda Meneghello, Federico Mercolini, Andrea Lo Vecchio, Shana Montalto, Cristina Meazza, Angelica Barone, Francesca Compagno, Paola Muggeo, Elena Soncini, Letizia Brescia, Eugenia Giraldi, Nagua Giurici, Rosa Maria Mura, Monica Cellini, Katia Perruccio, Valeria Petroni, Milena La Spina, Ottavio Ziino, Roberta Burnelli, Raffaella De Santis, Maurizio Mascarin, Valentina Barretta, Gloria Tridello, Simone Cesaro
Publikováno v:
Annals of hematology. 101(8)
COVID-19 has a mild clinical course with low mortality rate in general pediatric population, while variable outcomes have been described in children with cancer. Infectious diseases working party of the AIEOP collected data on the clinical characteri